2024-11-20 18:28:02
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma
Corporate/ 2023-07-23
Innovent Announces First Patient Dosed i...

SAN FRANCISCO and SUZHOU,China,May 25,2021-- Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical co...

Clinical Trial Application of ASC40 Combined with Bevacizumab to Treat Patients with Recurrent Glioblastoma Accepted by China NMPA
Corporate/ 2023-07-23
Clinical Trial Application of ASC40 Comb...

HANGZHOU and SHAOXING,China,May 25,2021-- Ascletis Pharma Inc. (HKEX code: 1672) today announces that following the consultation with China ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release